2018 Summit Power of A Award
The Diabetes Emergency Relief Coalition, received ASAE's 2018 Summit Power of A Award for helping to provide critical diabetes supplies to regions impacted by Hurricanes Harvey, Irma, and Maria.
New this year! CEU expands to two cities - Miami and Anaheim - making it more convenient for your schedule. EBR will occur in Miami only.
New Clinical Practice Guideline
Get the latest recommendations on how to diagnose and manage endocrine and growth disorders commonly found in childhood cancer survivors.
New and Improved EndoCareers
EndoCareers just got a big update! Visit the new career center to find targeted jobs in your area, and resources to help you care for your career.
- Review Proposes Best Practices for Diagnosing, Treating Klinefelter Syndrome
A paper recently published in Endocrine Reviews presents a comprehensive look at Klinefelter syndrome ...
- New Diabetes Helpline to Assist People Seeking Solutions to Insulin Affordability
Starting August 1, a new dedicated helpline called the Lilly Diabetes Solution Center will assist people who need help paying for their insulin...
- Join the Endocrine Society in Washington D.C. for a Briefing on Transgender Health
- Pediatric Health Q&A: Charles A. Sklar, MD
A talk with Charles A. Sklar, chair of the guideline writing committee that created the latest Endocrine Society Clinical Practice Guideline on hypothalamic-pituitary and growth disorders in survivors of childhood cancers.
- Case of the Month: Pediatric ESAP
You are asked to evaluate an 18-year-old girl because of concerns about hypocalcemia. At her recent precollege physical she described a several month history of fatigue and intermittent right upper-quadrant pain.
Clinical Endocrinology Update (CEU) will provide you with the opportunity to learn from and network with faculty at the forefront of endocrine practice and research. Early Registration is now open for:
- August 3 - 4, 2018 | Santa Fe Bone Symposium | Santa Fe, New Mexico, United States
- August 4 - 5, 2018 | Dimensions in Diabetes | Mumbai, India
- August 29 - 31, 2018 | World Congress on Gastroenterology and Therapeutics | Tokyo, Japan, Japan
Move your patients from educated to engaged with educational tools and resources from the Hormone Health Network.
MELK is overexpressed in human adrenocortical carcinoma cells and drives proliferation, tumorigenesis, and survival in a hypoxic environment. MELK is a therapeutic target for patients with ACC.
Hypoglycemia increases noradrenergic activity in the raphe nuclei, whereas changes in hypothalamic noradrenergic activity correlate with the counterregulatory response to hypoglycemia in humans.
The Testosterone Trials were conducted to determine if testosterone treatment would benefit older men with low testosterone. This report describes the Trials’ development and results and the lessons learned.
Both a clinical case patient with metastatic insulinoma and in vitro experiments demonstrated that everolimus directly suppresses insulin secretion, independently of its tumor regression effect.